BeOne Medicines AG (BVMF:B1ME34)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
U.S. Revenue	2.88B	1.96B
U.S. Revenue Growth	47.14%	73.50%
China Revenue	1.68B	1.41B
China Revenue Growth	19.00%	28.07%
Europe Revenue	611.37M	362.63M
Europe Revenue Growth	68.59%	79.51%
Rest of World Revenue	171.81M	78.81M
Rest of World Revenue Growth	118.00%	196.33%
Revenue (Total)	5.34B	3.81B
Revenue (Total) Growth	40.23%	54.96%

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
BRUKINSA Revenue	3.93B	2.64B
BRUKINSA Revenue Growth	48.57%	104.92%
TEVIMBRA Revenue	737.30M	620.84M
TEVIMBRA Revenue Growth	18.76%	15.69%
XGEVA Revenue	305.98M	224.40M
XGEVA Revenue Growth	36.35%	141.74%
BLINCYTO Revenue	104.22M	74.33M
BLINCYTO Revenue Growth	40.22%	36.78%
KYPROLIS Revenue	74.97M	66.17M
KYPROLIS Revenue Growth	13.30%	66.26%
POBEVCY Revenue	47.40M	53.51M
POBEVCY Revenue Growth	-11.42%	-5.37%
REVLIMID Revenue	-	36.03M
REVLIMID Revenue Growth	-	-52.61%
Other Product Revenue	-	60.04M
Other Product Revenue Growth	-	38.66%
Total Other Product Revenue	83.69M	96.07M
Total Other Product Revenue Growth	-12.88%	-19.48%
Total Product Revenue	5.28B	3.78B
Total Product Revenue Growth	39.75%	72.59%
Collaboration Revenue	60.97M	30.70M
Collaboration Revenue Growth	98.64%	-88.59%
Revenue (Total)	5.34B	3.81B
Revenue (Total) Growth	40.23%	54.96%

Updated Dec 31, 2025. Data Source: Fiscal.ai.